Clinical Trials
AMT has created broad clinical development plans to help understand which patients will benefit from our innovative therapies. If you would like more information on our trials, please access the detailed descriptions on clinicaltrials.gov.
AMT 101 – Ulcerative Colitis
Phase 2 clinical trial designed to evaluate the efficacy and safety of oral AMT-101 in adult subjects with moderate to severe ulcerative colitis
AMT 101 – Pouchitis
Phase 2 clinical trial designed to evaluate the efficacy and safety of oral AMT-101 in adult subjects with chronic pouchitis
AMT 101 – Ulcerative Colitis
Phase 2 clinical trial designed to evaluate the efficacy and safety of oral AMT-101 in adult subjects with moderate to severe ulcerative colitis in combination with or without anti-TNF therapy
AMT 101 – Rheumatoid Arthritis
Phase 2 clinical trial designed to evaluate the efficacy and safety of oral AMT-101 in adult subjects with moderate to severe rheumatoid arthritis with or without anti-TNF therapy
